In the United States a recent Nightly Business Report (NBR) revealed that the EVD scare is a big boon for the pharmaceutical industry, with investors buying up pharma stocks like crazy. Even the World Bank and IMF have created new types of loans for countries fighting outbreaks. Notice in the following how many legal drug makers, health service providers and international bankers around the World are jumping on the ebola bandwagon.
Australia: The British empire country has hired contractor Aspen Medical to staff a British empire military field hospital in Sierra Leone. The contract is worth $20-million AUD. 350 Aussie healthcare workers immediately “volunteered” to be hired by Aspen Health.
China: Hong Kong has begun ebola disinfection drills.
Cuba: Perhaps hoping to profit from its ebola response, the Cuban Medical Services is pushing its healthcare products at the 32nd International Trade Fair in Havana. Health administrators from 101 countries are expected to attend the fair. Cuban Medical Services is directly involved in healthcare ops in 40 countries, while individual healthcare workers in the tens of thousands are working in 66 countries.
Dominican Republic: Reports that the Caribbean country’s Health Ministry and Ministry of Defense are conducting joint ebola filovirus training at the Military Teaching Hospital in Santo Domingo.
European Union: The EU has pledged $1.25-billion USD to fight ebola in western Africa. But wait, most of that money will actually be going to various European companies who will be involved in medical supplies and testing drugs! On top of that the European Commission wants another $224-million just for the European pharmaceutical industry!
Portugal pledged $9915 worth of drugs to Guinea-Bissau. The New York based World Bank also loaned Guinea-Bissau $750-thousand. But wait, this isn’t the Guinea that’s dealing with an ebola outbreak, this is its neighbor Guinea-Bissau, which has yet to see an ebola case.
Japan: In Osaka, a woman from Guinea was quarantined for suspicion of being infected. She is locked down in a hospital with a fever, despite testing negative for the ebola filovirus. In Tokyo, a Japanese man returning from Liberia was quarantined. He has a fever and inflamed tonsils, however, his blood test showed no ebola.
Mali: The west-central African country reports 108 people under medical watch since a two years old girl died of ebola.
Nigeria: The African country is providing drugs and supplies worth more than $249-thousand to Sierra Leone. It’s part of a $3-million effort by Nigeria, which includes 600 healthcare workers under the leadership of the Economic Community Of West African States.
Switzerland (not a member of European Union): The UN World Health Organization praising Swissmedic for testing a new drug developed by the Public Health Agency of Canada. It’s been tested on non-human animals, but now will be tested on 115 human volunteers. The drug is called VSV-ZEBOV and is currently being tested on people in the United States. Switzerland is already testing another vaccine called ChAd3.
Vietnam: The South East Asian country has begun hospital drills in case of ebola outbreak. This comes after an immigrant from ebola stricken Guinea arrived sick. He later tested negative for EVD.
United States: In Nevada, Washoe County Health District administrators announced they have ordered a person who visited Liberia, Guinea and Sierra Leone to self monitor for symptoms. There was no report indicating the person was sick.
NBR reported that shares of two drugs makers shot up when investors learned they were working on ebola vaccines. The companies are Sarepta and Tekmira.
In New York, the University of Buffalo says the filovirus is much older than first thought, not several thousands years old but 23-million! Ebola and marburg are types of filovirus.
New York based World Bank revealed a new $450-million commercial loan scheme for countries hit by ebola outbreaks. They’re justifying the new loans based on a UN study that says Liberia and Sierra Leone lost the equivalent of $36-million in development projects because of the Ebola Virus Disease.
The World Bank also estimates the fight against the filovirus, just in western Africa, to cost $32.6-billion by the end of 2015.
New York based International Monetary Fund (IMF) is working with World Bank on a supposed “epidemic emergency fund”. However, it to is a loan. Countries can borrow money to pay for medical response. $500-million has been allocated for the new loan scheme.
In Washington DC, the Obama regime is asking the Congress to rape taxpayers for an additional $6-billion, to supposedly fight ebola. Congress has already raped taxpayers for $88-million, plus shifted $750-million in military spending to the fight against EVD.
The Department of Defense has picked five U.S. military bases as designated quarantine zones. They are Fort Hood and Fort Bliss inTexas, Fort Bragg in North Carolina, Joint Base Lewis-McChord in Washington and Joint Base Langley-Eustis in Virginia.
A drugs company revealed the Department of Defense gave it $8.5-million for development of an ebola vaccine based on the possibility the EVD has evolved to be transmittable by air: “In July 2014, Profectus BioSciences and the GNL were awarded a 3 year $8.5M grant from the DOD/JVAP to support development of a lyophilized trivalent VesiculoVax™-vectored vaccine to protect against all major strains of Ebola and Marburg viruses delivered as aerosols.”
The money went to Maryland based Profectus BioSciences.
But wait, there’s more! Profectus BioSciences revealed even more money spent on even more sinisterness: “In addition, the USACC has contracted for clinical evaluation of the VesiculoVax™ Zaire-Ebola virus vaccine to meet the current outbreak in West Africa. The $9.5 million award has been made with Battelle Memorial Institute through the Chemical, Biological, Radiological, & Nuclear Defense Information Analysis Center (CBRNIAC) contract, a Defense Technical Information Center (DTIC®) owned, Indefinite Delivery Indefinite Quantity (ID/IQ) contract vehicle for providing comprehensive scientific and technical research and analysis supporting the Department of Defense CBRN and Homeland Defense communities.”
Ebola filovirus is so virulent because when it enters your body its first targets are your immune cells. Once the immune system is weakened EVD then attacks your other cells.